The Role of Sitacure M 50/500 in Managing Post-Meal Blood Sugar Spikes in Type 2 Diabetes

Sitacure M 50/500, a combination of sitagliptin (50 mg) and metformin (500 mg), is designed to effectively manage post-meal blood sugar spikes in patients with type 2 diabetes. Sitagliptin works by inhibiting the DPP-4 enzyme, which enhances the action of incretin hormones like GLP-1 and GIP. These hormones help increase insulin production after eating and suppress glucagon release, which lowers the liver's glucose output. This dual action ensures better control over postprandial glucose levels, reducing the risk of blood sugar spikes that commonly occur after meals.

Metformin, on the other hand, complements sitagliptin by reducing the liver's production of glucose and improving insulin sensitivity in tissues, particularly in muscles. This helps manage fasting blood glucose levels as well, providing a comprehensive approach to blood sugar management. The combination of sitagliptin and metformin in Sitacure M 50/500 targets multiple pathways to keep blood sugar levels stable throughout the day, making it a reliable option for people struggling to control their blood sugar after meals.

More info : https://hertzpharma.in/sitacure.php